Regenxbio Inc. announced the publication of their phase 1/2a study results in The Lancet, showcasing...
read moreAurion Biotech recently administered its novel cell therapy, AURN001, to the first Canadian particip...
read moreNanoscope Therapeutics announced positive topline results from the phase 2b RESTORE trial, evaluatin...
read moreOpus Genetics recently completed the first stage of its innovative clinical trial, focusing on a new...
read moreResearchers at the University of Connecticut (UConn) have identified a potentially transformative fa...
read moreResearchers from Macau University of Science and Technology sheds light on the intersection of ophth...
read moreScientists at Columbia University Vagelos College of Physicians and Surgeons are pioneering a gene t...
read moreA phase II trial found that minocycline, despite its anti-inflammatory benefits, failed to slow visi...
read moreResearchers at the Institute of Inflammation and Aging have made strides in understanding the biolog...
read moreResearchers at the Broad Institute of MIT and Harvard have made a breakthrough in gene editing techn...
read more